Bill > SF1738

This bill establishes a prescription drug purchasing program administered by the Minnesota Commissioner of Human Services to help reduce prescription drug costs for medical assistance and MinnesotaCare enrollees. The program's key provisions include: creating a preferred drug list, negotiating directly with drug manufacturers and wholesalers to obtain price discounts and rebates, developing a drug formulary, and setting terms for pharmacy participation. The commissioner is authorized to contract with external entities for program support in the initial three years (2026-2028) but must make final determinations. All pharmacies licensed in Minnesota that agree to the program's terms can participate. The bill also requires the commissioner to seek federal approval for the program and mandates a report by December 15, 2026, on potentially expanding the program to include enrollees from additional health plan companies. The program is set to become effective on January 1, 2026, or upon receiving federal approval, whichever occurs later. The ultimate goals are to make prescription drugs available at the lowest possible cost, promote health through comprehensive prescription benefits, and maintain a list of the most effective drugs at the best prices.

Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF1738&ssn=0&y=2025